Article
A gene variation (rs12691) in the CCAT/enhancer binding protein α modulates glucose metabolism in metabolic syndrome.
Nutrition, metabolism, and cardiovascular diseases : NMCD - 1 May 2013
Delgado-Lista J, Perez-Martinez P, Garcia-Rios A, Phillips C M, Hall W, Gjelstad I M F, Lairon D, Saris W, Kieć-Wilk B, Karlström B, Drevon C A, Defoort C, Blaak E E, Dembinska-Kieć A, Risérus U, Lovegrove J A, Roche H M, Lopez-Miranda J
Abstract excerpt
BACKGROUND AND AIMS: CCAAT/enhancer-binding protein alpha (CEBPA) is a transcription factor involved in adipogenesis and energy homeostasis. Caloric restriction reduces CEBPA protein expression in patients with metabolic syndrome (MetS). A previous report linked rs12691 SNP in CEBPA to altered concentration of fasting triglycerides. Our objective was to assess the effects of rs12691 in glucose metabolism in...
Read the complete abstract on PubMed